Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1/2 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

INDUSTRY 245OTHER 86OTHER_GOV 2UNKNOWN 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Mesothelioma, Malignant 6Solid Tumor 4Mesothelioma 3Solid Tumors 2Pediatric Solid Tumors 2Advanced Solid Tumor 2Thymoma 1Stomach Neoplasms 1Solitary Fibrous Tumor, Pleural 1Solid Tumor, Adult 1Retinoblastoma 1Refractory Solid Tumors 1Pleural Effusion, Malignant 1Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm Metastasis 1Malignant Solid Tumor 1Lymphoma, Follicular 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoglobulin Light-chain Amyloidosis 1Heart Neoplasms 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Cholangiocarcinoma 1Childhood Solid Tumor 1Carcinoma, Hepatocellular 1

Interventions

fludarabine 1Interleukin-2 1Cyclophosphamide 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Solid Tumors × Other solid neoplasm × Clear all
NCT06955390 2025-05-02

Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors

Henan Cancer Hospital

Phase 1/2 Not yet recruiting
32 enrolled
Other solid neoplasm

Solid Tumors

NCT05648994 2022-12-13

TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors

Fujian Cancer Hospital

Phase EARLY_PHASE1 Unknown
30 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡